Aphria Inc. (OTCMKTS:APHQF) has welcomed the recent changes announced by the Canadian Federal Government in its Veteran Affairs policy on medicinal cannabis. The new guidelines restrict the daily amount approved to veterans to 3 grams unless they get a special exemption.
The management speaks
Vic Neufeld, the Chief Executive Officer of Aphria, said that they always meet patients’ orders reliant on the suggested prescription from their physician, so they are delighted that the new guidelines comprise provisions for veterans’ specific requirements and that treatment will be personalized accordingly. The company is dedicated to working with Health Canada and all supervisors to confirm that all medical cannabis patients, irrespective of medical coverage, receives the best possible treatment alternatives.
Aphria reported that they will work together with veterans to assist them in getting the drugs they need and the patient care they require. The company even have committed personnel in place to particularly work with this group. Another instance of the special care they provide veterans is CannWay brand, which was developed by veterans for their competitors and made up of a variety of strains that they picked as their desired strains to manage the numerous illnesses they deal with daily, covering chronic pain and PTSD.
Aphria have clear mechanism set to work with Health Canada within stringent regulatory framework and to the highest ethical morals when offering health care alternatives and doesn’t engage in the exercise of dual pricing between non-veteran and veteran platforms. The firm prides itself on its excellent patient care and in fact, the company’s exceptional patient care team continues to obtain impressive accolades from autonomous industry sites and associations, including winning the Canadian Cannabis Award 2016 for Best Customer Service. Neufeld added that they are extremely delighted of team and the significant impact they have on their patients’ lives daily.
In the last trading session, the stock price of Aphria jumped more than 21% to close the day at $4.10.
THE MORNING REPORT
Start your workday the right way with the news that matters most.
Your information is 100% secure with us and will never be shared Disclaimer & Privacy Policy
